N2非小细胞肺癌多学科综合治疗__培训课件.pptVIP

Author and Year Published # Pts Treatment Groups 5-Year Survival% P Value Arriagada et al[6] (IALT) 2004 1867 Cisplatin and either:EtoposideVinorelbineVindesineVinblastine 44.5 .03 OBS 40.4 Winton et al[7](JBR.10) 2004 482 Cisplatin-Vinorelbine 69 .03 OBS 54 Strauss et al[8](CALGB 9633) 2004 344 Carboplatin-Paclitaxel 71 (4 years) .028 OBS 59 (4 years) Rosell et al[9](ANITA) 2005 840 Cisplatin-Vinorelbine 51 .0131 OBS 43 Trial Stage IA Stage IB Stage II Stage IIIA IALT[6] Negative Negative Negative Positive NCIC[7] Not tested Negative Positive Not tested CALGB[8] Not tested Positive N